510(k) device
REMI Remote EEG Monitoring System
Epitel · Reduced- Montage Standard Electroencephalograph (OMC, Class II) · First FDA decision Jun 30, 2023, newest Mar 21, 2025Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "REMI Remote EEG"
MAUDE reports
0
Brand "REMI Remote EEG", since 2015
PubMed studies
0
Mentioning "REMI Remote EEG"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing REMI Remote EEG Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K243185 · Decided Mar 21, 2025 · 172 days after receipt
Device type: Reduced- Montage Standard Electroencephalograph (OMC) · Neurology & Neurosurgery
K230933 · Decided Jun 30, 2023 · 88 days after receipt
Device type: Reduced- Montage Standard Electroencephalograph (OMC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "REMI Remote EEG", any status and sponsor, newest update first.
- Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.Status unknown
Epitel, Inc.Not on our public-company list
NCT06027749 · 65 participants (planned) · Start Oct 13, 2023 · Primary completion Mar 30, 2025
Device: Epitel's™ Remote EEG Monitoring System's (REMI™) · For: Epilepsy; Seizures
Sites: Tampa, Florida; Charleston, South Carolina
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "REMI Remote EEG", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OMC
8 reports: 6 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "REMI Remote EEG"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OMC.
- SignalNED System (Model RE)Forest Devices, Inc. · 510(k) 2025
- Ceribell MonitorCeribell, Inc. · 510(k) 2026
- NX01 (NX01)Naox Technologies Sas · 510(k) 2025
- Natus BrainWatch SystemNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · 510(k) 2024
- Quex EdQx World, Ltd. · 510(k) 2024
- NEBA® Compact EEG2R Mobile HeadsetNeba Health, LLC · 510(k) 2023
- Neurosteer EEG RecorderNeurosteer, Inc. · 510(k) 2022
- RemiEpitel, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.